Olema Pharmaceuticals (OLMA) Short Interest Ratio & Short Volume $6.10 +0.31 (+5.35%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Olema Pharmaceuticals Short Interest DataOlema Pharmaceuticals (OLMA) has a short interest of 10.02 million shares. This marks a 17.06% increase in short interest from the previous month. The short interest ratio (days to cover) is 19.5, indicating that it would take 19.5 days of the average trading volume of 770,595 shares to cover all short positions.Current Short Interest10,020,000 sharesPrevious Short Interest8,560,000 sharesChange Vs. Previous Month+17.06%Dollar Volume Sold Short$101.40 millionShort Interest Ratio19.5 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares57,298,000 sharesPercentage of Shares Shorted17.49%Today's Trading Volume1,281,874 sharesAverage Trading Volume770,595 sharesToday's Volume Vs. Average166% Short Selling Olema Pharmaceuticals? Sign up to receive the latest short interest report for Olema Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOLMA Short Interest Over TimeOLMA Days to Cover Over TimeOLMA Percentage of Float Shorted Over Time Ad Behind the MarketsWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.Take these 4 steps today to protect your retirement NOW Olema Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202410,020,000 shares $101.40 million +17.1%N/A19.5 $10.12 11/15/20248,560,000 shares $78.50 million +3.0%N/A17.6 $9.17 10/31/20248,310,000 shares $95.81 million -2.2%N/A17.9 $11.53 10/15/20248,500,000 shares $99.03 million -0.1%N/A15.8 $11.65 9/30/20248,510,000 shares $101.61 million -3.6%N/A14.2 $11.94 9/15/20248,830,000 shares $112.14 million -0.1%N/A13.4 $12.70 Get the Latest News and Ratings for OLMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Olema Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20248,840,000 shares $104.31 million +3.0%N/A12.7 $11.80 8/15/20248,580,000 shares $106.31 million +6.7%N/A9.2 $12.39 7/31/20248,040,000 shares $129.93 million +10.0%N/A8.3 $16.16 7/15/20247,310,000 shares $96.05 million +14.6%N/A7.7 $13.14 6/30/20246,380,000 shares $69.03 million -18.0%N/A6.8 $10.82 6/15/20247,780,000 shares $96.16 million -4.8%N/A8.4 $12.36 5/31/20248,170,000 shares $79.09 million -4.3%N/A7.9 $9.68 5/15/20248,540,000 shares $84.12 million +1.7%N/A10.4 $9.85 4/30/20248,400,000 shares $85.43 million -6.4%N/A10.5 $10.17 4/15/20248,970,000 shares $97.32 million +10.7%N/A11.1 $10.85 3/31/20248,100,000 shares $91.69 million +60.1%N/A9.9 $11.32 3/15/20245,060,000 shares $58.44 million +3.9%N/A6.4 $11.55 2/29/20244,870,000 shares $60.39 million -21.2%N/A5.9 $12.40 2/15/20246,180,000 shares $91.53 million -7.9%N/A6.8 $14.81 1/31/20246,710,000 shares $87.50 million -5.2%N/A7.5 $13.04 1/15/20247,080,000 shares $82.13 million +0.7%N/A8.3 $11.60 12/31/20237,030,000 shares $98.63 million +5.7%N/A8.5 $14.03 12/15/20236,650,000 shares $81.13 million +27.6%N/A8.5 $12.20 11/30/20235,210,000 shares $72.68 million +88.8%N/A8.1 $13.95 11/15/20232,760,000 shares $46.42 million No ChangeN/A6.4 $16.82 10/31/20232,760,000 shares $36.68 million +26.0%7.3%7.9 $13.29 10/15/20232,190,000 shares $27.66 million +10.6%5.8%7.6 $12.63 9/30/20231,980,000 shares $24.45 million +12.5%5.4%7.1 $12.35 9/15/20231,760,000 shares $22.69 million +10.7%4.8%5.9 $12.89 8/31/20231,590,000 shares $16.14 million -9.7%4.4%4.1 $10.15 8/15/20231,760,000 shares $19.03 million -4.4%5.0%4.8 $10.81 7/31/20231,840,000 shares $15.92 million -4.7%5.3%5.1 $8.65 7/15/20231,930,000 shares $15.81 million +5.5%5.6%5.4 $8.19 6/30/20231,830,000 shares $16.52 million +55.1%5.3%5 $9.03 6/15/20231,180,000 shares $10.71 million +14.6%3.4%3.7 $9.08 5/31/20231,030,000 shares $5.33 million No Change3.0%5.2 $5.17 5/15/20231,030,000 shares $6.89 million +1.0%3.0%6.2 $6.69 4/30/20231,020,000 shares $4.89 million -6.4%3.0%6 $4.79 4/15/20231,090,000 shares $3.99 million -4.4%3.2%6.5 $3.66Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. 3/31/20231,140,000 shares $3.96 million +3.6%3.3%6.3 $3.47 3/15/20231,100,000 shares $4.38 million -1.8%3.2%7.5 $3.98 2/28/20231,120,000 shares $4.59 million -21.1%3.3%7.5 $4.10 2/15/20231,420,000 shares $6.38 million No Change4.1%9.1 $4.49 1/31/20231,420,000 shares $6.86 million -7.2%4.1%8.7 $4.83 1/15/20231,530,000 shares $6.35 million +1.3%4.5%10.3 $4.15 12/30/20221,510,000 shares $3.70 million -5.6%4.4%12.5 $2.45 12/15/20221,600,000 shares $3.92 million +1.3%4.7%12.3 $2.45 11/30/20221,580,000 shares $4.53 million -3.1%4.6%10.7 $2.87 11/15/20221,630,000 shares $5.22 million +4.5%4.7%10.2 $3.20 10/31/20221,560,000 shares $5.87 million +3.3%4.5%8 $3.76 10/15/20221,510,000 shares $4.32 million -3.2%4.4%7.3 $2.86 9/30/20221,560,000 shares $4.31 million -7.1%4.5%4.7 $2.76 9/15/20221,680,000 shares $6.89 million -6.2%4.9%4.2 $4.10 8/31/20221,790,000 shares $7.07 million -6.3%5.2%4 $3.95 8/15/20221,910,000 shares $8.16 million +6.1%5.6%3.7 $4.27 7/31/20221,800,000 shares $9.04 million +0.6%5.2%3.4 $5.02 7/15/20221,790,000 shares $8.41 million -14.8%5.2%3.3 $4.70 6/30/20222,100,000 shares $8.55 million -23.6%6.1%4.6 $4.07 6/15/20222,750,000 shares $10.20 million +10.9%8.1%6 $3.71 5/31/20222,480,000 shares $7.09 million -9.5%7.3%5.9 $2.86 5/15/20222,740,000 shares $5.92 million +1.5%8.1%6.9 $2.16 4/30/20222,700,000 shares $6.89 million +13.5%8.1%7.2 $2.55 4/15/20222,380,000 shares $7.33 million -18.2%7.2%5.7 $3.08 3/31/20222,910,000 shares $12.40 million +1.8%8.8%6.9 $4.26 3/15/20222,860,000 shares $11.13 million -5.0%8.6%6.3 $3.89 2/28/20223,010,000 shares $14.09 million +14.5%9.1%5.9 $4.68 2/15/20222,630,000 shares $13.47 million +0.8%7.9%3.1 $5.12 1/31/20222,610,000 shares $16.78 million +8.8%8.2%3.1 $6.43 1/15/20222,400,000 shares $16.06 million -37.5%7.6%3 $6.69 12/31/20213,840,000 shares $35.94 million +15.0%12.1%4.7 $9.36 12/15/20213,340,000 shares $30.69 million -17.9%10.5%4.2 $9.19 11/30/20214,070,000 shares $35.61 million +23.0%12.9%5.4 $8.75 11/15/20213,310,000 shares $87.02 million +22.6%10.5%8.6 $26.29 10/29/20212,700,000 shares $72.90 million +16.4%8.7%8 $27.00 10/15/20212,320,000 shares $71.25 million -3.7%7.5%7 $30.71 9/30/20212,410,000 shares $66.42 million +8.1%7.8%8.1 $27.56 9/15/20212,230,000 shares $60.81 million +8.3%7.2%7.8 $27.27 8/31/20212,060,000 shares $61.64 million +4.0%6.6%7.6 $29.92 8/13/20211,980,000 shares $53.06 million -17.8%6.4%7.8 $26.80 7/30/20212,410,000 shares $56.59 million -0.8%7.3%9.7 $23.48 7/15/20212,430,000 shares $60.51 million +7.5%7.2%10.5 $24.90 6/30/20212,260,000 shares $63.23 million +23.5%6.7%10.6 $27.98 6/15/20211,830,000 shares $55.83 million -5.2%5.4%8.6 $30.51 5/28/20211,930,000 shares $53.96 million +35.9%5.7%9.4 $27.96 5/14/20211,420,000 shares $34.18 million +6.8%4.2%7.5 $24.07 4/30/20211,330,000 shares $39.83 million +16.7%4.5%7.6 $29.95 4/15/20211,140,000 shares $40.88 million +32.4%3.5%7.1 $35.86 3/31/2021861,000 shares $24.90 million +94.8%2.6%5.5 $28.92 3/15/2021441,900 shares $20.82 million -4.6%1.4%3 $47.12Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad)Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. 2/26/2021463,300 shares $19.29 million +4.0%1.5%4.6 $41.63 2/12/2021445,400 shares $23.50 million -4.7%1.4%2.9 $52.76 1/29/2021467,400 shares $19.67 million +14.9%1.4%2.9 $42.09 1/15/2021406,800 shares $16.83 million No Change1.2%2.3 $41.37 OLMA Short Interest - Frequently Asked Questions What is Olema Pharmaceuticals' current short interest? Short interest is the volume of Olema Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 10,020,000 shares of OLMA short. Learn More on Olema Pharmaceuticals' current short interest. What is a good short interest ratio for Olema Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OLMA shares currently have a short interest ratio of 20.0. Learn More on Olema Pharmaceuticals's short interest ratio. Is Olema Pharmaceuticals' short interest increasing or decreasing? Olema Pharmaceuticals saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 10,020,000 shares, an increase of 17.1% from the previous total of 8,560,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Olema Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Olema Pharmaceuticals: Kiniksa Pharmaceuticals, Ltd. (5.57%), Ocular Therapeutix, Inc. (6.78%), Maravai LifeSciences Holdings, Inc. (3.13%), Travere Therapeutics, Inc. (9.70%), Aurinia Pharmaceuticals Inc. (4.34%), Praxis Precision Medicines, Inc. (8.53%), Arvinas, Inc. (13.13%), Harrow, Inc. (8.06%), Day One Biopharmaceuticals, Inc. (28.49%), Ardelyx, Inc. (10.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Olema Pharmaceuticals stock? Short selling OLMA is an investing strategy that aims to generate trading profit from Olema Pharmaceuticals as its price is falling. OLMA shares are trading up $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Olema Pharmaceuticals? A short squeeze for Olema Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OLMA, which in turn drives the price of the stock up even further. How often is Olema Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OLMA, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies KNSA Short Squeeze OCUL Short Squeeze MRVI Short Squeeze TVTX Short Squeeze AUPH Short Squeeze PRAX Short Squeeze ARVN Short Squeeze HROW Short Squeeze DAWN Short Squeeze ARDX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OLMA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olema Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Olema Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OLMA Stock Alerts